These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2837590)

  • 21. Aneusomy of chromosomes 7, 8, and 17 and amplification of HER-2/neu and epidermal growth factor receptor in Gleason score 7 prostate carcinoma: a differential fluorescent in situ hybridization study of Gleason pattern 3 and 4 using tissue microarray.
    Skacel M; Ormsby AH; Pettay JD; Tsiftsakis EK; Liou LS; Klein EA; Levin HS; Zippe CD; Tubbs RR
    Hum Pathol; 2001 Dec; 32(12):1392-7. PubMed ID: 11774175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas: implications for prognosis and response to endocrine therapy.
    Visakorpi T; Kallioniemi OP; Paronen IY; Isola JJ; Heikkinen AI; Koivula TA
    Br J Cancer; 1991 Sep; 64(3):578-82. PubMed ID: 1911201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Flow cytometric analysis of localized adenocarcinoma of the prostate: the use of archival DNA analysis in conjunction with pathological grading to predict clinical outcome following radical retropubic prostatectomy.
    Ring KS; Karp FS; Olsson CA; O'Toole K; Bixon R; Benson MC
    Prostate; 1990; 17(2):155-64. PubMed ID: 2399191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flow cytometric DNA analysis of advanced prostatic adenocarcinoma.
    Wu WJ; Huang MS; Wang HJ; Chiang PH; Huang CH; Chiang CP
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1993 Mar; 9(3):122-30. PubMed ID: 8510195
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flow cytometric DNA analysis of fresh prostatic resections. Correlation with conventional prognostic parameters in patients with prostate cancer.
    Hussain MH; Powell I; Zaki N; Maciorowski Z; Sakr W; KuKuruga M; Visscher D; Haas GP; Pontes JE; Ensley JF
    Cancer; 1993 Nov; 72(10):3012-9. PubMed ID: 7693326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flow cytometric analysis of prostatic carcinoma with and without bone marrow metastasis.
    Furusato M; Allsbrook WC; Kato H; Takahashi H; Miyasaka Y; Nomura K; Asano K; Ito T; Aizawa S
    Adv Exp Med Biol; 1992; 324():189-91. PubMed ID: 1492616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in localized prostatic carcinoma.
    Pontes JE; Wajsman Z; Huben RP; Wolf RM; Englander LS
    J Urol; 1985 Dec; 134(6):1137-9. PubMed ID: 4057404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage D1 prostatic adenocarcinoma: significance of nuclear DNA ploidy patterns studied by flow cytometry.
    Winkler HZ; Rainwater LM; Myers RP; Farrow GM; Therneau TM; Zincke H; Lieber MM
    Mayo Clin Proc; 1988 Feb; 63(2):103-12. PubMed ID: 3339904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deoxyribonucleic acid cytometric analysis of prostate core biopsy specimens: relationship to serum prostate specific antigen and prostatic acid phosphatase, clinical stage and histopathology.
    Konchuba AM; Schellhammer PF; Kolm P; Clements MA; Wright GL
    J Urol; 1993 Jul; 150(1):115-9. PubMed ID: 7685419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of prognosis in untreated stage A2 prostatic carcinoma.
    Mohler JL; Partin AW; Epstein JI; Becker RL; Mikel UV; Sesterhenn IA; Mostofi FK; Gleason DF; Sharief Y; Coffey DS
    Cancer; 1992 Jan; 69(2):511-9. PubMed ID: 1728382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer.
    Alcaraz A; Barranco MA; Corral JM; Ribal MJ; Carrió A; Mallofré C; Llopis J; Cetina A; Alvarez-Vijande R
    Prostate; 2001 Apr; 47(1):29-35. PubMed ID: 11304727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chromosomal imbalances, loss of heterozygosity, and immunohistochemical expression of TP53, RB1, and PTEN in intraductal cancer, intraepithelial neoplasia, and invasive adenocarcinoma of the prostate.
    Bettendorf O; Schmidt H; Staebler A; Grobholz R; Heinecke A; Boecker W; Hertle L; Semjonow A
    Genes Chromosomes Cancer; 2008 Jul; 47(7):565-72. PubMed ID: 18383208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric DNA analysis of specimen mammography-guided fine-needle aspirates of ductal carcinoma in situ.
    Stomper PC; DeBloom JR; Winston JS; Stewart CC
    J Exp Clin Cancer Res; 2000 Sep; 19(3):309-15. PubMed ID: 11144524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flow cytometric analysis of nuclear DNA content of duct cell carcinoma of the pancreas.
    Yoshimura T; Manabe T; Imamura T; Imanishi K; Ohshio G; Yamabe H; Kitamura O; Matsumoto M; Ogasahara K; Takasan H
    Cancer; 1992 Sep; 70(5):1069-74. PubMed ID: 1325268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraductal carcinoma of the prostate.
    Robinson B; Magi-Galluzzi C; Zhou M
    Arch Pathol Lab Med; 2012 Apr; 136(4):418-25. PubMed ID: 22458904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA image cytometry of prostatic carcinoma: a comparison of needle core biopsy and subsequent prostatectomy specimens.
    Leung CS; Zbieranowski I; Demers J; Murray D
    Mod Pathol; 1994 Feb; 7(2):195-9. PubMed ID: 8008743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A DNA cytometric proliferation index improves the value of the DNA ploidy pattern as a prognosticating tool in patients with carcinoma of the prostate.
    Ahlgren G; Lindholm K; Falkmer U; Abrahamsson PA
    Urology; 1997 Sep; 50(3):379-84. PubMed ID: 9301701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA ploidy and proliferation heterogeneity in human prostate cancers.
    Shankey TV; Jin JK; Dougherty S; Flanigan RC; Graham S; Pyle JM
    Cytometry; 1995 Sep; 21(1):30-9. PubMed ID: 8529468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-derived xenografts reveal that intraductal carcinoma of the prostate is a prominent pathology in BRCA2 mutation carriers with prostate cancer and correlates with poor prognosis.
    Risbridger GP; Taylor RA; Clouston D; Sliwinski A; Thorne H; Hunter S; Li J; Mitchell G; Murphy D; Frydenberg M; Pook D; Pedersen J; Toivanen R; Wang H; Papargiris M; Lawrence MG; Bolton DM
    Eur Urol; 2015 Mar; 67(3):496-503. PubMed ID: 25154392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.